Varicocelectomy: Can Sex-hormones Predict Improvements in Semen Quality?

Sponsor
Copenhagen University Hospital at Herlev (Other)
Overall Status
Terminated
CT.gov ID
NCT01296230
Collaborator
Rigshospitalet, Denmark (Other)
3
2
1
72
1.5
0

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if the pre-operative levels of sex-hormones can be used to identify the varicocele patients who can expect improvements in their semen parameters following varicocelectomy.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Hormone and semen measurements before varicocelectomy
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
3 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Varicocelectomy: Can Sex-hormones Predict Improvements in Semen Quality?
Study Start Date :
Feb 1, 2011
Anticipated Primary Completion Date :
Feb 1, 2017
Anticipated Study Completion Date :
Feb 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Hormone/semen measurements before and after varicocelectomy

We will measure sex-hormone and semen quality in patients both before and after varicocelectomy. The purpose is to asses if preoperative hormone levels are predictive for who will have improved semen quality after surgery.

Procedure: Hormone and semen measurements before varicocelectomy
Before surgery we will measure sex-hormone levels and semen parameters. This will be repeated after the varicocelectomy to record any changes.

Outcome Measures

Primary Outcome Measures

  1. Change in semen parameters [February 2017 (anticipated duration of the study)]

Secondary Outcome Measures

  1. Change in hormone levels [February 2017 (anticipated end of the study)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Varicocele (grade 1-3) and surgery planned for this condition

  • At least 18 years of age

Exclusion Criteria:
  • Fever within 3 months before the first semen sample

  • Malformations of the uro-genital tract

  • Karyotype other than 46, XY or Y micro deletions

  • Endocrine disease

  • Chronic disease

  • Medications which reduce semen quality

  • Epididymitis within 6 months before surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Department of Growth and Reproduction GR, Section 5064, Rigshospitalet Copenhagen Denmark 2100
2 Department of Urology, Herlev Hospital Herlev Denmark 2730

Sponsors and Collaborators

  • Copenhagen University Hospital at Herlev
  • Rigshospitalet, Denmark

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Copenhagen University Hospital at Herlev
ClinicalTrials.gov Identifier:
NCT01296230
Other Study ID Numbers:
  • H-2-2010-067
First Posted:
Feb 15, 2011
Last Update Posted:
May 24, 2013
Last Verified:
Feb 1, 2012
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 24, 2013